DOCUSATE SODIUM
- Manufacturer
- Safecor Health, LLC
- Effective date
- 2025-01-08
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 00:51:40
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
Active Ingredient (in each 5 mL = 1 teaspoonful)
Docusate Sodium 50 mg
Purpose
Stool Softener
Use:
Relief of occasional constipation
WARNINGS:
OTC - DO NOT USE SECTION
Do not use * when abdominal pain, nausea, or vomiting are present * for a period longer than 1 week unless directed by a doctor
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you * have noticed a sudden change in bowel habits that persist over a period of 2 weeks * are taking mineral oil
OTC - STOP USE SECTION
Stop use and ask a doctor if you have rectal bleeding or failure to have a bowel movement within 3 days.
These could be signs of a serious condition. * a skin rash occurs * you experience throat irritation
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast feeding, ask a health care professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep this and all drugs out of reach of children. In case of overdose, get medical help or contact a Poison Control Center immediately. In case of eye contact, flush with water.
DOSAGE & ADMINISTRATION SECTION
Directions: * Must be given in a 6 oz to 8 oz glass of milk or fruit juice to prevent throat irritation | |
| Adults and children 12 years of age and over | 5 mL (1 teaspoon) to 40 mL (8 teaspoons) or as directed by a doctor |
| Children 6 to 12 years of age | 4 mL to 15 mL (3 teaspoons) or as directed by a doctor |
| Children 3 to 6 years of age | 2 mL to 6 mL or as directed by a doctor |
| Children under 3 years of age | 1 mL to 4 mL or as directed by a doctor |
1 teaspoon = 5 mL
OTHER SAFETY INFORMATION
Other information: Each teaspoon (5 mL) contains: sodium 5 mg. Store at room temperature 20°C-25°C (68°F-77°F); excursions
between 15°C-30°C (59°F-86°F) are allowed. Protect from excessive heat. Protect from light. For more info call 1-800-447-1006.
INACTIVE INGREDIENT SECTION
Inactive ingredients: FD&C red #40, flavor, methylparaben, poloxamer, polyethylene glycol, propylene glycol, propylparaben, purified
water, sodium benzoate, sodium citrate, and sucralose.
NDC: 48433-220-10 Docusate Sodium Liquid 100 mg/10 mL Unit Dose Cup
Mfd. in the U.S.A.
Distributed by: Safecor Health, LLC
4060 Business Park Drive, Columbus, OH 43204 Rev: 11/2020 PN5473
3 4843322010 8
Principal Display Panel - Box Label
SAFECOR
HEALTH
Docusate Sodium Liquid
100 mg / 10 ml
Contains 40 (10 ml) Unit Dose Cups
See monograph for complete drug information.
NDC: 48433-220-40
QTY: 40
Lot: 21A0079
Exp: 2023-03-31
Store at room temperature 20°C-25°C (68°F-77°F);
excursions between 15°C-30°C (59°F-86°F) are allowed.
Protect from excessive heat. Protect from light.
This package design is not child resistant. For institutional use only.
Shake well before use.
3 48433 22040 5
Pkg By: Safecor Health, LLC Columbus, OH 43204
Questions or Comments: Call 1-800-447-1006
GTIN: 00348433220405
SN: 212802331
Exp; 2023-03-31
Lot 21A0079 PN5689.C
Principal Display Panel - Lid Label
Delivers 1 0 mL
NDC 48433-220-10
Docusate
Sodium Liquid
100 mg/10mL
SHAKE WELL
348433220108
Pkg By: Safecor Health, LLC
Columbus, OH 43204
PN5618.B
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1248119 | docusate sodium 50 MG in 5 mL Oral Suspension | PSN | 3 |
| 1248119 | docusate sodium 10 MG/ML Oral Suspension | SCD | 3 |
| 1248119 | docusate sodium 100 MG per 10 ML Oral Suspension | SY | 3 |
| 1248119 | docusate sodium 150 MG per 15 ML Oral Suspension | SY | 3 |
| 1248119 | docusate sodium 50 MG per 5 ML Oral Suspension | SY | 3 |
| 1248119 | DOSS Sodium 10 MG/ML Oral Suspension | SY | 3 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 48433-220-10 | 2023-01-31 | C162847 | 48780-1 | f386c649-d87d-0266-e053-dadaa90a7c1a | SAFECOR HEALTH Docusate Sodium Liquid Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 48433-220-10 | DOCUSATE SODIUM | 10 mL in 1 CUP, UNIT-DOSE | LIQUID | 10 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 48433-220-10 | ML - Milliliter | 48433-220 | 9184ffe3-708c-47a6-b2d9-0ce1419e9070 | 1 | 2023-03-13 |
| 54859-813-16 | ML - Milliliter | 54859-813 | 25502fa9-6f5b-4d15-898f-034a45e4599b | 1 | 2025-05-14 |
Products#
Every source-derived product name is available through these pages.
- DOCUSATE SODIUM
- DOCUSATE
- FD&C RED NO. 40
- METHYLPARABEN
- POLOXAMER 124
- POLYETHYLENE GLYCOL, UNSPECIFIED
- PROPYLENE GLYCOL
- PROPYLPARABEN
- WATER
- SODIUM BENZOATE
- SODIUM CITRATE
- SUCRALOSE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 48433-220 | 48433-220-10 |
| 54859-813 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DOCUSATE SODIUM | F05Q2T2JA0 | ACTIB |
| FD&C RED NO. 40 | WZB9127XOA | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| POLOXAMER 124 | 1S66E28KXA | IACT |
| POLYETHYLENE GLYCOL, UNSPECIFIED | 3WJQ0SDW1A | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| SODIUM CITRATE | 1Q73Q2JULR | IACT |
| SUCRALOSE | 96K6UQ3ZD4 | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Docusate Sodium Liquid | DOCUSATE SODIUM | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION | 2d8bdd3e-f6e6-43f5-b3b0-e5a882cae41c | 2025-12-31 | Warnings | 54859-813 |
| DOCUSATE SODIUM | DOCUSATE SODIUM | Safecor Health, LLC | efe4bf81-fb99-4755-aa23-4f8df5973be8 | 2025-01-08 | Warnings | 48433-220-10 48433-220 48433022010 3b918dfb-629d-4eef-ba71-d2ee2f97747f efe4bf81-fb99-4755-aa23-4f8df5973be8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

